A systematic approach to impurity identification

Following the receipt of all available information including any spectral data, how the request for assistance is handled by the group(s) responsible for providing structural characterization will depend, in part, on how structure elucida-tion/characterization function is organized, which can vary from company to company and even between sites within a single company. The most prominent models for the organization of structure characterization units within the pharmaceutical industry are very briefly considered in Section 5.1.1. 

Structure elucidation functions within the pharmaceutical industry fall principally into three organizational constmcts. These range from each discipline 

---